As of Apr 28
| -0.78 / -5.29%|
The 7 analysts offering 12-month price forecasts for Cross Country Healthcare Inc have a median target of 18.00, with a high estimate of 23.00 and a low estimate of 17.00. The median estimate represents a +28.85% increase from the last price of 13.97.
The current consensus among 8 polled investment analysts is to Buy stock in Cross Country Healthcare Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.